Skip to main content
. 2020 Mar 20;15(3):e0230024. doi: 10.1371/journal.pone.0230024

Table 3. Risk factors associated with Gd-EOP-DTPA-related TSM.

Risk factors No TSM TSM p =
Number of patients 170 40
Gender female 87 (51.2) 20 (50.0) >0.999
male 83 (48.8) 20 (50.0)
Age (years) median (IQR) 61.6 (52.6–73.1) 64.0 (55.9–74.5) 0.283
Tumor etiology HCC/CCC 29 (17.1) 10 (25.0) 0.176
metastasis 80 (47.0) 20 (50.0)
no malignancy 61 (35.9) 10 (25.0)
Prior TSM yes 27 (15.9) 15 (37.5) 0.005
Breath-hold capacity (≥17s) * yes 45/58 (77.6) 13/58 (22.4) 0.025
median (IQR) 20 (18.4–20) 20 (16.6–20) 0.100
Pleural effusion yes 12 (7.1) 5 (12.5) 0.256
Ascites yes 14 (8.2) 3 (7.5) 0.878
Cirrhosis yes 28 (16.5) 5 (12.5) 0.535
Lung fibrosis yes 7 (4.2) 2 (5.1) 0.797
Flow rate (mL/s) 1 85 (50.0) 15 (37.5) 0.154
2 85 (50.0) 25 (62.5)
Scan time (s) 17 24 (14.1) 12 (30.0) 0.064
BMI (kg/m2) ** 24.9 (22.3–31.0) 24.8 (22.5–28.0) 0.622
CT CM allergy yes 4 (2.4) 2 (5.0) 0.595
Allergy general ** yes 18/85 (21.2) 4/25 (16.0) 0.333
Cardiac problems ** yes 13/85 (15.3) 7/25 (28.0) 0.100

Categories are presented as N (%); SD = Standard deviation; IQR = Interquartile range; Mann-Whitney-U Test was used for quantitative data, all other p-values result from χ2-test for qualitative data (or Fisher's Test if any cell has an expected cell count less than 5); HCC/CCC = Hepatocellular/Cholangiocellular carcinoma; TSM = transient severe respiratory motion; CT CM = CT contrast media; BMI = Body mass index; Allergy general = any allergic disposition to substances or food; Cardiac problems = Hypertension, atrial fibrillation, others;

* = Only data from patients at site B with breath-hold training;

** = Data was not recorded at site A; significant p-values are depicted in bold.